QLT paid executives U.S. cash equivalent, raising salaries 40%

Article Abstract:

Vancouver, BC-based QLT Inc., which is a pharmaceutical manufacturer, reported that it gave its top executives a 40% raise by converting salaries into U.S. dollars. QLT, which is led by co-founder and chief executive officer Julia Levy, is waiting for FDA approval of a new blindness treatment drug.

QLT Inc.

---

Inex (again) sees drug plans turn to 'zero value'

Article Abstract:

Inex Pharmaceuticals Corp.'s flagship cancer drug, the project that Mr. David Main focused on five years ago received a surprising regulatory setback on December 1, 2004. Mr. Main stated that Inex's current work force of 150 people and its monthly rate of spending of $1.5-million would be cut.

Securities, Company securities, Company financing, Inex Pharmaceuticals Corp.

---

Caprion booms in biotech

Article Abstract:

The two-year-old Caprion Pharmaceuticals Inc. announced a private sale of stock worth $52.5-million to investors in both Canada and the United States. This is one of the largest private placements ever made in the Canadian biotech industry.

Caprion Pharmaceuticals Inc.

Similar abstracts:

• Abstracts: Oil prices fall on news U.S. may step in. Winter heating bills loom as oil nears $35
• Abstracts: AutoNation changes gears. More car dealers now videotape sales. Retailers rewrite auto sales rules
• Abstracts: Dunlap, 4 others face SEC lawsuit. Razor rivals face restraining order. 28 states sue over CD price policy
• Abstracts: The dollar closes at a 2-month high. Dollar slides half cent on rate worries. Dollar expected to climb above 70 cents
• Abstracts: Factory slowdown continues as tech firms slash production. Factory shipments fall 0.6% in April. Aircraft, electronic goods top higher output

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.